DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 121 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$23,264,880
+150.0%
3,286,000
+148.6%
0.51%
+157.8%
Q2 2023$9,306,880
-59.6%
1,322,000
-52.2%
0.20%
-61.3%
Q1 2023$23,060,100
+40.1%
2,765,000
+173.2%
0.51%
+39.7%
Q1 2022$16,455,000
-29.5%
1,012,000
-40.0%
0.37%
-24.9%
Q4 2021$23,353,000
+592.6%
1,686,140
+618.6%
0.49%
+642.4%
Q3 2021$3,372,000
-92.5%
234,643
-91.7%
0.07%
-91.7%
Q2 2021$44,821,000
+69.2%
2,835,000
+8.8%
0.80%
+42.9%
Q1 2021$26,497,000
-39.1%
2,605,380
-55.4%
0.56%
-35.2%
Q4 2020$43,477,000
+184.0%
5,835,810
+30.9%
0.86%
+130.3%
Q3 2020$15,308,000
-27.9%
4,456,5190.0%0.37%
-39.6%
Q2 2020$21,235,000
+128.2%
4,456,519
-4.2%
0.62%
+109.5%
Q1 2020$9,306,000
-57.7%
4,652,926
-27.0%
0.30%
-58.0%
Q4 2019$21,994,000
+176.7%
6,375,143
+129.8%
0.70%
+116.7%
Q3 2019$7,949,000
-66.7%
2,774,643
-55.9%
0.32%
-62.2%
Q2 2019$23,850,000
-55.2%
6,292,980
-3.7%
0.86%
-58.0%
Q1 2019$53,216,000
-4.6%
6,537,566
-5.4%
2.04%
-8.6%
Q4 2018$55,770,000
+5.8%
6,910,7890.0%2.23%
+18.2%
Q3 2018$52,729,000
+51.8%
6,910,789
+14.0%
1.89%
+54.8%
Q2 2018$34,744,000
-1.1%
6,063,496
-17.7%
1.22%
+0.2%
Q1 2018$35,138,000
-0.8%
7,366,460
+2.1%
1.22%
-12.7%
Q4 2017$35,418,000
+35.9%
7,213,393
+45.0%
1.39%
+18.7%
Q3 2017$26,071,000
+17.2%
4,975,451
+24.4%
1.17%
-1.0%
Q2 2017$22,236,000
-14.2%
3,999,202
+29.6%
1.19%
+18.6%
Q1 2017$25,916,000
+26.5%
3,085,236
-4.7%
1.00%
+18.6%
Q4 2016$20,495,000
+5.6%
3,237,734
-26.4%
0.84%
-6.6%
Q3 2016$19,412,000
+102.1%
4,401,846
+384.8%
0.90%
+130.4%
Q1 2014$9,606,000
+45.5%
907,920
+4.5%
0.39%
+14.6%
Q4 2013$6,601,000
-44.5%
868,570
-46.8%
0.34%
-38.2%
Q3 2013$11,884,0001,632,3600.55%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
VHCP Management II, LLC 6,071,142$38,430,00018.43%
RTW INVESTMENTS, LP 4,078,895$25,819,0009.72%
VHCP Management, LLC 1,155,104$7,312,0007.86%
RA Capital Management 2,989,795$18,925,0002.68%
DLD Asset Management, LP 1,258,700$7,967,0002.61%
Avoro Capital Advisors LLC 1,631,502$10,327,0002.09%
Ghost Tree Capital, LLC 1,150,000$7,280,0001.75%
GREAT POINT PARTNERS LLC 725,000$4,589,0000.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,237,734$20,495,0000.84%
Baker Brothers Advisors 10,963,944$69,402,0000.68%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders